デフォルト表紙
市場調査レポート
商品コード
1418451

臨床試験機器および付随ソリューション市場レポート:2030年までの動向、予測、競合分析

Clinical Trial Equipment & Ancillary Solutions Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

臨床試験機器および付随ソリューション市場レポート:2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

臨床試験機器および付随ソリューションの動向と予測

世界の臨床試験機器および付随ソリューション市場は、2024年から2030年にかけてCAGR 8.2%で成長すると予測されます。この市場の主な促進要因は、医薬品・ヘルスケア分野の急成長と研究開発投資の増加です。i相、II相、III相の各市場における機会により、世界の臨床試験機器および付随ソリューション市場の将来は有望です。

臨床試験機器および付随ソリューション市場の洞察

Lucintelの予測では、新興市場における規則や規制の変更により、供給/ロジスティクスが予測期間中に最も高い成長を遂げる見込みです。

この市場の中では、効果的なサプライチェーンとロジスティクスの需要増加により、第3相が最大のセグメントであり続けると思われます。

アジア太平洋は、患者数の増加により予測期間中に最も高い成長が見込まれます。

よくある質問

Q1.市場の成長予測は?

A1.世界の臨床試験機器および付随ソリューション市場は、2024年から2030年にかけてCAGR 8.2%で成長する見込みです。

Q2.市場の成長に影響を与える主な促進要因は?

A2.この市場の主な促進要因は、医薬品・ヘルスケア分野の急成長と研究開発投資の増加です。

Q3.市場の主要セグメントは?

A3.第I相、第II相、第III相の各市場における機会により、臨床試験機器および付随ソリューション市場の将来性は有望です。

Q4.市場の主要企業は?

A4.主な臨床試験機器および付随ソリューション企業は以下の通りです。

  • Ancillare
  • Imperial Crs
  • Woodley Equipment
  • Thermo Fisher Scientific
  • Parexel International
  • Emsere
  • Quipment Sas
  • Irm
  • Marken
  • Myonex

Q5.今後、最大となる市場セグメントは?

A5.Lucintelは、新興市場における規則や規制の変更により、供給/物流が予測期間中に最も高い成長を遂げると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は?

A6.APACは患者数の増加により予測期間中に最も高い成長が見込まれます。

Q7.レポートのカスタマイズは可能?

A7.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の臨床試験機器および付随ソリューション市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界の臨床試験機器および付随ソリューション市場の動向(2018~2023年)および予測(2024~2030年)
  • 製品別の世界の臨床試験機器および付随ソリューション市場
    • 調達
    • レンタル
    • 供給・物流
    • サービス
    • その他
  • フェーズ別の世界の臨床試験機器および付随ソリューション市場
    • フェーズI
    • フェーズII
    • フェーズIII

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の臨床試験機器および付随ソリューション市場
  • 北米の臨床試験機器および付随ソリューション市場
  • 欧州臨床試験機器および付随ソリューション市場
  • アジア太平洋の臨床試験機器および付随ソリューション市場
  • その他地域の臨床試験機器および付随ソリューション市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界の臨床試験機器および付随ソリューション市場の成長機会
    • フェーズ別の世界の臨床試験機器および付随ソリューション市場の成長機会
    • 地域別の世界の臨床試験機器および付随ソリューション市場の成長機会
  • 世界の臨床試験機器および付随ソリューション市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の臨床試験機器および付随ソリューション市場の能力拡大
    • 世界の臨床試験機器および付随ソリューション市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Ancillare
  • Imperial CRS
  • Woodley Equipment
  • Thermo Fisher Scientific
  • PAREXEL International
  • Emsere
  • Quipment SAS
  • IRM
  • Marken
  • Myonex
目次

Clinical Trial Equipment & Ancillary Solutions Trends and Forecast

The future of the global clinical trial equipment & ancillary solutions market looks promising with opportunities in the phase I, phase II, phase III markets. The global clinical trial equipment & ancillary solutions market is expected to grow with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rapid growth in the sectors of medicines and healthcare and rising r&d investments.

A more than 150-page report is developed to help in your business decisions.

Clinical Trial Equipment & Ancillary Solutions by Segment

The study includes a forecast for the global clinical trial equipment & ancillary solutions by product, phase, and region.

Clinical Trial Equipment & Ancillary Solutions Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Sourcing
  • Rental
  • Supply/Logistics
  • Service
  • Others

Clinical Trial Equipment & Ancillary Solutions Market by Phase [Shipment Analysis by Value from 2018 to 2030]:

  • Phase I
  • Phase III
  • Phase III

Clinical Trial Equipment & Ancillary Solutions Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clinical Trial Equipment & Ancillary Solutions Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clinical trial equipment & ancillary solutions companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clinical trial equipment & ancillary solutions companies profiled in this report include-

  • Ancillare
  • Imperial CRS
  • Woodley Equipment
  • Thermo Fisher Scientific
  • Parexel International
  • Emsere
  • Quipment SAS
  • IRM
  • Marken
  • Myonex

Clinical Trial Equipment & Ancillary Solutions Market Insights

Lucintel forecasts that supply/logistics is expected to witness highest growth over the forecast period due to changes in rules & regulations in emerging markets.

Within this market, phase iii will remain the largest segment due to rise in the demand for effective supply chain and logistics.

APAC is expected to witness highest growth over the forecast period due to growing patient population.

Features of the Global Clinical Trial Equipment & Ancillary Solutions Market

Market Size Estimates: Clinical trial equipment & ancillary solutions market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clinical trial equipment & ancillary solutions market size by product, phase, and region in terms of value ($B).

Regional Analysis: Clinical trial equipment & ancillary solutions market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, phase, and regions for the clinical trial equipment & ancillary solutions market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clinical trial equipment & ancillary solutions market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for clinical trial equipment & ancillary solutions market?

Answer: The global clinical trial equipment & ancillary solutions market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the clinical trial equipment & ancillary solutions market?

Answer: The major drivers for this market are rapid growth in the sectors of medicines and healthcare and rising r&d investments.

Q3. What are the major segments for clinical trial equipment & ancillary solutions market?

Answer: The future of the clinical trial equipment & ancillary solutions market looks promising with opportunities in the phase I, phase II, phase III markets.

Q4. Who are the key clinical trial equipment & ancillary solutions market companies?

Answer: Some of the key clinical trial equipment & ancillary solutions companies are as follows.

  • Ancillare
  • Imperial Crs
  • Woodley Equipment
  • Thermo Fisher Scientific
  • Parexel International
  • Emsere
  • Quipment Sas
  • Irm
  • Marken
  • Myonex

Q5. Which clinical trial equipment & ancillary solutions market segment will be the largest in future?

Answer: Lucintel forecasts that supply/logistics is expected to witness highest growth over the forecast period due to changes in rules & regulations in emerging markets.

Q6. In clinical trial equipment & ancillary solutions market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing patient population.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clinical trial equipment & ancillary solutions market by product (sourcing, rental, supply/logistics, service, and others), phase (phase i, phase ii, and phase iii), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clinical Trial Equipment & Ancillary Solutions Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clinical Trial Equipment & Ancillary Solutions Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clinical Trial Equipment & Ancillary Solutions Market by Product
    • 3.3.1: Sourcing
    • 3.3.2: Rental
    • 3.3.3: Supply/Logistics
    • 3.3.4: Service
    • 3.3.5: Others
  • 3.4: Global Clinical Trial Equipment & Ancillary Solutions Market by Phase
    • 3.4.1: Phase I
    • 3.4.2: Phase II
    • 3.4.3: Phase III

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clinical Trial Equipment & Ancillary Solutions Market by Region
  • 4.2: North American Clinical Trial Equipment & Ancillary Solutions Market
    • 4.2.2: North American Clinical Trial Equipment & Ancillary Solutions Market by Phase: Phase I, Phase II, and Phase III
  • 4.3: European Clinical Trial Equipment & Ancillary Solutions Market
    • 4.3.1: European Clinical Trial Equipment & Ancillary Solutions Market by Product: Sourcing, Rental, Supply/Logistics, Service, and Others
    • 4.3.2: European Clinical Trial Equipment & Ancillary Solutions Market by Phase: Phase I, Phase II, and Phase III
  • 4.4: APAC Clinical Trial Equipment & Ancillary Solutions Market
    • 4.4.1: APAC Clinical Trial Equipment & Ancillary Solutions Market by Product: Sourcing, Rental, Supply/Logistics, Service, and Others
    • 4.4.2: APAC Clinical Trial Equipment & Ancillary Solutions Market by Phase: Phase I, Phase II, and Phase III
  • 4.5: ROW Clinical Trial Equipment & Ancillary Solutions Market
    • 4.5.1: ROW Clinical Trial Equipment & Ancillary Solutions Market by Product: Sourcing, Rental, Supply/Logistics, Service, and Others
    • 4.5.2: ROW Clinical Trial Equipment & Ancillary Solutions Market by Phase: Phase I, Phase II, and Phase III

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clinical Trial Equipment & Ancillary Solutions Market by Product
    • 6.1.2: Growth Opportunities for the Global Clinical Trial Equipment & Ancillary Solutions Market by Phase
    • 6.1.3: Growth Opportunities for the Global Clinical Trial Equipment & Ancillary Solutions Market by Region
  • 6.2: Emerging Trends in the Global Clinical Trial Equipment & Ancillary Solutions Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clinical Trial Equipment & Ancillary Solutions Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Trial Equipment & Ancillary Solutions Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ancillare
  • 7.2: Imperial CRS
  • 7.3: Woodley Equipment
  • 7.4: Thermo Fisher Scientific
  • 7.5: PAREXEL International
  • 7.6: Emsere
  • 7.7: Quipment SAS
  • 7.8: IRM
  • 7.9: Marken
  • 7.10: Myonex